| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5ea5dcc3f5fd9ed3749c2e254484b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383 |
| filingDate |
2014-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c2affe627afc6287d1da6e6d8a7316f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edde93d3c3e80c959d73330da7d5651d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0149e10c9b9fc8b3d34ee6314e37887 |
| publicationDate |
2015-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015066696-A1 |
| titleOfInvention |
Fused morphlinopyrimidines and methods of use thereof |
| abstract |
The present invention relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113834891-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108997138-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017177837-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110256461-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110256461-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113834891-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019510822-A |
| priorityDate |
2013-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |